| Address:
|
400 OYSTER POINT BOULEVARD, SUITE 502
-- |
| City: |
SOUTH SAN FRANCISCO |
|
State: |
CA |
|
Zip Code: |
94080 |
| Telephone: |
650-624-9600 |
|
Description of Business
|
Primary SIC Code:
2834 |
| (As filed with the SEC)
|
|
|
Anesiva, Inc. is a biopharmaceutical company focused on the development and
commercialization of novel therapeutic treatments for pain management. Our
portfolio of products includes:
. ZingoT (lidocaine hydrochloride monohydrate) powder intradermal injection
system, which was approved by the FDA in August 2007 to reduce the pain
associated with peripheral IV insertions or blood draws in children three
to 18 years of age. In October 2007, we announced that our Phase 3
clinical trial in adults requested by the Food and Drug Administration
(FDA) met its primary endpoint. In March 2008, we submitted to the FDA a
supplemental New Drug Application for the use of Zingo in adults.
. ... More ... |
| Date |
12-mos
Rolling EPS |
Dividend |
P/E
Ratio |
| 09/2009 | -0.61 | NA | N/E | | 06/2009 | -0.87 | NA | N/E | | 03/2009 | -1.14 | NA | N/E | | 12/2008 | -1.29 | NA | N/E | | 09/2008 | -2.25 | NA | N/E | | 06/2008 | -2.27 | NA | N/E | | 03/2008 | -2.23 | NA | N/E | | 12/2007 | -2.12 | NA | N/E |
Key Financial Ratios and Statistics |
FYE:
12/31 |
| Profitability |
2008 |
Leverage |
2008 |
| Net Inc/Comm Equity | -0.34 | Total Liab/Total Assets | 3.62 | | Net Inc/Total Assets | -33.81 | Total Liab/Inv Cap | -1.38 | | Net Inc/Inv Cap | 12.90 | Total Liab/Comm Equity | 0.04 | | Pretax Inc/Net Sales | -171.37 | Interest Coverage Ratio | -39.86 | | Net Inc/Net Sales | -339.52 | Curr Debt/Equity | NA | | Cash Flow/Net Sales | -246.13 | LTD/Equity | NA | | SG&A/NetSales | 42.77 | Total Debt/Equity | NA |
| Asset Utilization
|
|
Liquidity |
|
| Net Receivables Turnover | NA | Quick Ratio | 0.21 | | Inventory Turnover | NA | Current Ratio | 0.22 | | Inventory Day Sales | NA | Net Rec/Curr Assets | NA | | Net Sales/Work Cap | -0.04 | Inv/Curr Assets | 0.09 | | Net Sales/PP&E | 1.39 | | |
Income Statement (Millions) |
| |
9/30/2009
|
6/30/2009
|
3/31/2009
|
12/31/2008
|
|
Total Revenues(Net Sales)
|
0.00
|
NA
|
NA
|
0.00
|
|
Cost of Goods Sold
|
NA
|
NA
|
NA
|
-4.01
|
|
Selling & Admin Exps
|
1.76
|
1.51
|
5.67
|
-9.71
|
|
Operating Income
|
-2.30
|
-3.23
|
-7.52
|
16.91
|
|
Interest Exp
|
0.35
|
0.45
|
0.05
|
0.32
|
|
Pretax Income
|
-2.47
|
-3.63
|
-7.50
|
14.22
|
|
Other Income
|
0.18
|
0.05
|
0.07
|
-2.27
|
|
Net Income Bef Extraordinary ...
|
NA
|
NA
|
NA
|
NA
|
|
Net Income
|
-2.31
|
-3.27
|
-7.58
|
-36.90
|
|
Assets
|
9/30/2009
|
6/30/2009
|
3/31/2009
|
12/31/2008
|
|
Cash & Short Term Investments
|
0.01
|
0.92
|
0.32
|
1.25
|
|
Receivables - Total
|
NA
|
NA
|
NA
|
NA
|
|
Inventories - Total
|
NA
|
0.19
|
0.19
|
0.22
|
|
Total Current Assets
|
0.70
|
1.50
|
1.34
|
2.49
|
|
Net Property, Plant & Equipment
|
0.10
|
0.13
|
0.16
|
0.22
|
|
Total Assets
|
1.11
|
1.95
|
1.83
|
3.05
|
|
Liabilities
|
|
|
|
|
|
Accounts Payable
|
11.62
|
10.30
|
11.14
|
11.05
|
|
Debt in Current Liabilities
|
9.83
|
9.33
|
4.77
|
NA
|
|
Total Current Liabilities
|
21.44
|
19.62
|
15.91
|
11.05
|
|
Long-Term Debt
|
NA
|
NA
|
NA
|
NA
|
|
Total Liabilities
|
21.70
|
20.37
|
17.14
|
11.05
|
|
Stockholder's Equity
|
|
|
|
|
|
Minority Interest
|
NA
|
NA
|
NA
|
NA
|
|
Preferred Stock
|
0.00
|
NA
|
NA
|
NA
|
|
Common Stock
|
0.04
|
0.04
|
0.04
|
0.04
|
|
Retained Earnings
|
-325.14
|
-322.83
|
-319.56
|
-311.98
|
|
Treasury Stock
|
NA
|
NA
|
NA
|
NA
|
|
Total Stockholders' Equity
|
-20.59
|
-18.42
|
-15.31
|
-8.00
|
|
Total Liabilities and Stockholders' Equity
|
1.11
|
1.95
|
1.83
|
3.05
|
Cash Flow Summary (Millions) |
|
Categories
|
9/30/2009
|
6/30/2009
|
3/31/2009
|
12/31/2008
|
|
Net Cash Provided by Operating Activities
|
-1.11
|
-3.81
|
-5.56
|
-14.01
|
|
Net Cash Provided by Investing Activities
|
0.00
|
0.02
|
0.22
|
-1.38
|
|
Net Cash Provided by Financing Activities
|
0.20
|
4.40
|
5.00
|
-20.00
|
Annual Summary Data (Millions) |
| Year |
Sales |
Net
Income |
EPS |
| 12/2004 | 36.38 | -39.85 | -- | | 12/2005 | 0.00 | -33.52 | -- | | 12/2006 | 0.09 | -55.57 | -2.69 | | 12/2007 | 0.05 | -59.28 | -2.12 | | 12/2008 | 0.30 | -103.21 | -1.29 | | Growth Rates | -69.77 | -- | -- |
| Type |
Date(Q,M) |
No.
Owners |
Shares
Held (000s) |
%
Own |
| Institutional | 12/31/09 | 18 | 5,471 | 13.52 |
|
Report Date :
1/11/2010
 Copyright
2010, EDGAR Online, Inc. All
rights reserved. Replication or redistribution of EDGAR Online, Inc. content is
expressly prohibited without the prior written consent of EDGAR Online, Inc.
EDGAR Online, Inc. shall not be liable for any errors or delays in the content,
or for any actions taken in reliance thereon.
|
|
|